Analyze. Answer. Advance
Answering the right questions on time and with high-quality data is the key to achieving your objectives. At Inotiv, clinical decision support is our focus: We deliver the comprehensive and integrated range of right-size toxicology services, analysis, bioanalysis, and DMPK and consulting solutions essential to your success.
In choosing a laboratory partner, Expect more: more attention, more insight, and a superlative experience. You’ve worked hard to get this far, and you deserve a provider aligned to your needs and goals.
Through scientific leadership and ongoing investments, Inotiv delivers a comprehensive range of nonclinical and analytical services that will exceed your expectations. Benefit from our long and impeccable regulatory history, world-class team of scientists, and track record of providing attentive, decisive service.
Studies: Pilot/lead optimization, Acute, Sub-chronic, Chronic
Species: Rodents, Canines, Nonhuman Primates, Swine/Minipigs, Rabbits, Guinea pigs
Routes of Administration: Oral (Gavage, Capsule/tablet), Parenteral (Intramuscular, Intraperitoneal, Intravenous, Subcutaneous, Sublingual, Dermal, Intradermal, Ocular, Intravaginal, Rectal, Intranasal)
Our in vivo automated sampling lab is one of the largest in the USA. We have stationed 48 automated sampling Culex systems for a quick turn-around of your PKPD data. Our goal is to provide you with studies that meet your unique information needs while minimizing the number of study animals.
Seventh Wave offers pharmacology studies in liver humanized FRG® KO mice through a partnership with Yecuris to provide the most predictive approach available to study new human liver disease therapies. As with our other laboratory services, Seventh Wave supports our clients with study design, conduct, and result interpretation.
We have more than 2 years of experience developing and validating pharmacology studies in these models and have successfully executed multiple client sponsored studies.
Seventh Wave is the exclusive provider of services related to hepatitis B virus and C virus pharmacology studies using the humanized FRG® KO model. Yecuris’ models are highly repopulated with human liver cells, making them and ideal candidate for infectious disease and gene delivery/gene therapy studies:
Infectious disease: These models have been validated for hepatotropic disease, especially hepatitis. Please contact us to discuss additional applications in liver disease.
Gene Delivery/Gene therapy: We have demonstrated this model’s utility for evaluating gene therapy and gene delivery technology, evaluating expression using in vivo imaging.
BASi® has proven experience and expertise with the FDA guidance documents and regulations on In Vitro Bioequivalence studies. The group's pharmaceutical product testing expertise mixed with the corporation's knowledge of bioequivalence studies and regulations creates the perfect match for our In Vitro services. BASi leverages the FDA guidances and all applicable literature sources to develop a sound scientific, regulatory plan.
All Seventh Wave pathologists are ACVP board certified and our service is fully GLP compliant. Seventh Wave pathologists have, on average, approximately 20 years of drug development experience.
We assign a pathologist to provide expert evaluation of your drug candidate whether your study is performed at Seventh Wave or at another laboratory. The same pathologist can stay with your candidate, providing scientific continuity and consistency of evaluations throughout the life cycle of your compound.
Histology Lab Services:
Our laboratory provides industry-recognized expertise in quantitative microscopy. Consultation and design-based techniques coupled with broad histochemical/immunohistochemical capabilities and knowledge of various disease states create the best possible quantitative evaluations.
INOTIV has not received any reviews.
INOTIV has not received any endorsements.